CHAPLIN DAVID 4
4 · MATEON THERAPEUTICS INC · Filed Jun 22, 2018
Insider Transaction Report
Form 4
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-06-20+258,171→ 258,171 totalExercise: $0.22Exp: 2024-06-20→ Common Stock (258,171 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per shares (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the Amended and Restated Mateon Therapeutics, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy.
- [F2]The Stock Options will vest in full on June 20, 2019, subject to Dr. Chaplin's continued service on the Board of Directors as of such date.